Skip to main content

Protective effects of quercetin on thioacetamide-induced acute liver damage and its related biochemical and pathological alterations

Abstract

Background

Acute liver damage may be followed by biochemical, behavioral, and pathological alterations, which can end up in serious complications and even death.

Aim

The aim of this study was to determine whether quercetin, a flavonoid compound, which is also known to have cell-protective, antioxidant, and anti-inflammatory effects, has any protective impacts against thioacetamide (TAA)-induced liver damage in rats.

Methods

Thirty-six Sprague–Dawley rats were divided into three groups: group C1, normal rats; group C2, rats that received a single dose of TAA (350 mg/kg) intraperitoneally; and group E, rats that received a single dose of TAA (350 mg/ kg)+300 mg/kg quercetin intraperitoneally. At the end, liver enzymes and plasma ammonia (NH4) were measured, and pathological analysis of the liver carried out.

Results

The measured serological markers except for total bilirubin (alanine aminotransferase, aspartate aminotransferase, and NH4) showed a significant decrease in group E compared with group C2. The quercetin-treated group showed a significantly lower clinical grade of encephalopathy. Pathological findings showed a significantly lower piecemeal necrosis in group E compared with group C2. Moreover, there was a nonsignificant decrease in focal necrosis, apoptosis, and focal inflammation in group E compared with group C2. Portal inflammation scores were lower in group E than in group C2. Therefore, quercetin significantly affected the grade of liver damage, as group E had lower grades compared with group C2 (P<0.05).

Conclusion

Overall, quercetin showed positive effects on both the liver injury and its related behavioral and biochemical changes.

References

  1. Schiodt FV, Atillasoy E, Shakil AO, Schiff ER, Caldwell C, Kowdley KV, et al. Etiology and outcome for 295 patients with acute liver failure in the United States. Liver Transpl Surg 1999; 5:29–34.

    CAS  PubMed  Google Scholar 

  2. Bernal W, Hall C, Karvellas CJ, Auzinger G, Sizer E, Wendon J. Arterial ammonia and clinical risk factors for encephalopathy and intracranial hypertension in acute liver failure. Hepatology 2007; 46:1844–1852.

    CAS  PubMed  Google Scholar 

  3. Blei AT, Córdoba J. Hepatic encephalopathy. Am J Gastroentrol 2001; 96:1968–1977.

    CAS  Google Scholar 

  4. Kosenko E, Kaminsky Y, Lopata O, Muravyov N, Kaminsky A, Hermenegildo C, et al. Nitroarginine, an inhibitor of nitric oxide synthase, prevents changes in superoxide radical and antioxidant enzymes induced by ammonia intoxication. Metab Brain Dis 1998; 13:29–41.

    CAS  PubMed  Google Scholar 

  5. Butterworth RF, Norenberg MD, Felipo V, Ferenci P, Albrecht J, Blei AT, et al. Experimental models of hepatic encephalopathy: ISHEN guidelines. Liver Int 2009; 29:783–788.

    PubMed  Google Scholar 

  6. Guerit JM, Amantini A, Fischer C, Kaplan PW, Mecarelli O, Schnitzler A, et al. Neurophysiological investigations of hepatic encephalopathy: ISHEN practice guidelines. Liver Int 2009; 29:789–796.

    PubMed  Google Scholar 

  7. Butterworth RF. Hepatic encephalopathy: a central neuroinflammatory disorder? Hepatology 2011; 53:1372–1376.

    PubMed  Google Scholar 

  8. Balkan J, Dogru-Abbasoglu S, Kanbagli O, Cevikbas U, Aykac-Toker G, Uysal M. Taurine has a protective effect against thioacetamide-induced liver cirrhosis by decreasing oxidative stress. Hum Exp Toxicol 2001;20:251–254.

    CAS  PubMed  Google Scholar 

  9. Baskaran Y, Periyasamy V, Venkatraman AC. Investigation of antioxidant, anti-inflammatory and DNA-protective properties of eugenol in thioacetamide-induced liver injury in rats. Toxicology 2010; 268:204–212.

    Google Scholar 

  10. Raso GM, Meli R, Di Carlo G, Pacilio M, Di Carlo R. Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1. Life Sci 2001; 68:921–931.

    CAS  PubMed  Google Scholar 

  11. Formica JV, Regelson W. Review of the biology of quercetin and related bioflavonoids. Food Chem Toxicol 1995; 33:1061–1080.

    CAS  PubMed  Google Scholar 

  12. Seyan AS, Hughes RD, Shawcross DL. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol 2010; 16:3347–3357.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Chu CJ, Lee FY, Wang SS, Chang FY, Lin HC, Wu SL, et al. Establishment of an animal model of hepatic encephalopathy. Zhonghua Yi Xue Za Zhi 2000; 63:263–269.

    CAS  PubMed  Google Scholar 

  14. Theocharis SE, Margeli AP, Agapitos EV, Mykoniatis MG, Kittas CN, Davaris PS. Effect of hepatic stimulator substance administration on tissue regeneration due to thioacetamide-induced liver injury in rats. Scand J Gastroentero 1998; 33:656–663.

    CAS  Google Scholar 

  15. Farjam M, Dehdab P, Abbassnia F, Mehrabani D, Tanideh N, Pakbaz S, et al. Thioacetamide-induced acute hepatic encephalopathy in rat: behavioral, biochemical and histological changes. Iran Red Crescent Med J 2012; 14:164–170.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Ishak K, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22:696–699.

    CAS  PubMed  Google Scholar 

  17. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SHB, et al. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137:947–954.

    PubMed  Google Scholar 

  18. Squires RH Jr, Shneider BL, Bucuvalas J, Alonso E, Sokol RJ, Narkewicz MR, et al. Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr 2006; 148:652–658.

    PubMed  PubMed Central  Google Scholar 

  19. De David C, Rodrigues G, Bona S, Meurer L, Gonzalez-Gallego J, Tunon MJ, et al. Role of quercetin in preventing thioacetamide-induced liver injury in rats. Toxicol Pathol 2011; 39:949–957.

    PubMed  Google Scholar 

  20. Uskokovic-Markovic S, Milenkovic M, Topic A, Kotur-Stevuljevic J, Stefanovic A, Antic-Stankovic J. Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in wistar rats. J Pharm Pharm Sci 2007; 10:340–349.

    CAS  PubMed  Google Scholar 

  21. Tunez I, Munoz MC, Villavicencio MA, Medina FJ, de Prado EP, Espejo I, et al. Hepato- and neurotoxicity induced by thioacetamide: protective effects of melatonin and dimethylsulfoxide. Pharmacol Res 2005; 52:223–228.

    CAS  PubMed  Google Scholar 

  22. Esfahani SA, Esmaeilzadeh E, Bagheri F, Emami Y, Farjam M. The effect of co-enzyme q10 on acute liver damage in rats, a biochemical and pathological study. Hepat Mon 2013; 13:13685.

    Google Scholar 

  23. Ashkani-Esfahani S, Bagheri F, Emami Y, Esmaeilzadeh E, Azarpira N, Hassanabadi N, et al. Protective effects of co-enzyme Q10 on thioacetamide-induced acute liver damage and its correlation with behavioral, biochemical, and pathological factors. Iran Red Crescent Med J 2016; 18:29166.

    Google Scholar 

  24. Deng YR, Ding L, Wu SX, Wang HQ. Studies on chemical constituents in herb of Lamium maculatum var. kansuense (II). Zhongguo Zhong Yao Za Zhi 2005; 30:272–274.

    CAS  PubMed  Google Scholar 

  25. Duthie SJ, Dobson VL. Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro. Eur J Nutr 1999; 38:28–34.

    CAS  PubMed  Google Scholar 

  26. Sasaki M, Nakamura H, Tsuchiya S, Horie S, Kashiwayanagi M, Saito T, et al. Quercetininduced PC12 cell death accompanied by caspasemediated DNA fragmentation. Biol Pharm Bull 2007; 30:682–686.

    CAS  PubMed  Google Scholar 

  27. Böhm H, Boeing H, Hempel J, Raab B, Kroke A. Flavonols, flavone and anthocyanins as natural antioxidants of food and their possible role in the prevention of chronic diseases [article in German]. Z Ernahrungswiss 1988; 37:147–163.

    Google Scholar 

  28. Erdman JW, Balentine D, Arab L, Beecher G, Dwyer JT, Folts J, et al. Flavonoids and heart health: Proceedings of the ILSI North America Flavonoids Workshop, May 31–June 1, 2005, Washington, DC. J Nutr 2007; 137:718–737.

    Google Scholar 

  29. Williamson G, Manach C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am J Clin Nutr 2005; 81:243–255.

    Google Scholar 

  30. Pavanato A, Tunon MJ, Sanchez-Campos S, Marroni CA, Llesuy S, Gonzalez-Gallego J, et al. Effects of quercetin on liver damage in rats with carbon tetrachloride-induced cirrhosis. Dig Dis Sci 2003; 48:824–829.

    CAS  PubMed  Google Scholar 

  31. Janbaza KH, Saeedb SA, Gilani AH. Studies on the protective effects of caffeic acid and quercetin on chemical-induced hepatotoxicity in rodents. Phytomedicine 2004; 11:424–430.

    Google Scholar 

  32. Domitrovic R, Jakovac H, Marchesi VV, Vladimir-Knezevic S, Cvijanovic O, Tadic Z, et al. Differential hepatoprotective mechanisms of rutin and quercetin in CCl4-intoxicated BALB/cN mice. Acta Pharmacol Sin 2012; 33:1260–1270.

    CAS  PubMed  PubMed Central  Google Scholar 

  33. Norenberg MD. Astrocytic-ammonia interactions in hepatic encephalopathy. Semin Liver Dis 1996; 16:245–253.

    CAS  PubMed  Google Scholar 

  34. Häussinger D, Kircheis G, Fischer R, Schliess F, Dahl SV. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low grade cerebral edema? J Hepatol 2000; 32:1035–1038.

    PubMed  Google Scholar 

  35. Abo-Salem OM, Abd-Ellah MF, Ghonaim MM. Hepatoprotective activity of quercetin against acrylonitrile-induced hepatotoxicity in rats. J Biochem Mol Toxicol 2011; 25:386–392.

    CAS  PubMed  Google Scholar 

  36. Ji L, Ma Y, Wang Z, Cai Z, Pang C, Wang Z. Quercetin prevents pyrrolizidine alkaloid clivorine-induced liver injury in mice by elevating body defense capacity. PLoS One 2014; 9:e98970.

  37. Weiying Z, Liu W, Yang B, Wu L, Yang J, Zou T, et al. Quercetin protects against perfluorooctanoic acid-induced liver injury by attenuating oxidative stress and inflammatory response in mice. Int Immunopharmacol 2015; 28:129–135.

    Google Scholar 

  38. Middleton EJ, Kandaswami C, Theoharides TC. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52:673751.

    Google Scholar 

  39. Bastianetto S, Quirion R. Natural extracts as possible protective agents of brain aging. Neurobiol Aging 2002; 23:891–897.

    CAS  PubMed  Google Scholar 

  40. Achliya GS, Wadodkar SG, Dorle AK. Evaluation of hepatoprotective effect of Amalkadi Ghrita against carbon tetrachlorideinduced hepatic damage in rats. J Ethnopharmacol 2004; 90:229–232.

    PubMed  Google Scholar 

  41. Rao GM, Rao CV, Pushpangadan P, Shirwaikar A. Hepatoprotective effects of rubiadin, a major constituent of Rubia cordifolia Linn. J Ethnopharmacol 2006; 103:484–490.

    CAS  PubMed  Google Scholar 

  42. Chen X. Protective effects of quercetin on liver injury induced by ethanol. Pharmacogn Mag 2010; 6:135–141.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fereshteh Bagheri MD.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Ashkani-Esfahani, S., Bagheri, F., Azarpira, N. et al. Protective effects of quercetin on thioacetamide-induced acute liver damage and its related biochemical and pathological alterations. Egypt J Intern Med 28, 123–127 (2016). https://doi.org/10.4103/1110-7782.200965

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1110-7782.200965

Keywords

  • acute liver damage
  • pathological change
  • quercetin
  • thioacetamide